Nihon Kohden Corporation (OTCMKTS:NHNKY) Short Interest Update

Nihon Kohden Corporation (OTCMKTS:NHNKY) was the target of a large increase in short interest during the month of June. As of June 15th, there was short interest totaling 8,583 shares, an increase of 104.6% from the May 31st total of 4,196 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily volume of 28,647 shares, the short-interest ratio is currently 0.3 days.

Nihon Kohden Stock Performance

Shares of NHNKY opened at $8.77 on Wednesday. The firm has a market capitalization of $1.47 billion, a price-to-earnings ratio of 14.86 and a beta of 0.39. Nihon Kohden has a one year low of $8.12 and a one year high of $14.21. The stock’s fifty day moving average is $8.99 and its 200-day moving average is $10.04.

Nihon Kohden (OTCMKTS:NHNKY) last posted its quarterly earnings data on Thursday, May 14th. The company reported $0.34 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.10. The business had revenue of $453.10 million during the quarter, compared to the consensus estimate of $414.40 million. Nihon Kohden had a net margin of 6.08% and a return on equity of 9.46%. Analysts forecast that Nihon Kohden will post 0.6 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, Zacks Research upgraded Nihon Kohden to a “hold” rating in a research note on Monday, April 27th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy”.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.